(L28) Hypersensitivity Flashcards
What are the characteristics of type I hypersensitivity? Timing and mechanism. L28 S4
- Immediate response
- mediated by IgE and results from the action of mediators secreted by mast cells.
- most of the time triggered by enviromental antigens which activate mast cells in an IgE dependent manner
What are the mast cell mediators involved in Type I hypersensitivities? L28 S5
Histamine: -vasodilator and increased permeability
Protease: -tissue damage
Prostaglandins -vasodilator
Leukotrienes: -smooth muscle contraction
Cytokines: -inflammation/leukocyte recruitment
(HPPLC)
What is Atopy
genetic tendency to develop allergic diseases.
What is unique to first and subsequent exposures in type I hypersensitivities? L28 S6-7
1) First exposure to allergen: -causes B cell maturation and production of plasma cells that produce IgE -no hypersensitivity response as allergen is likely gone before IgE is produced
2) Subsequent exposures to allergen: -circulating IgE bind allergen and bind to FcεRII (CD23) -degranulation occurs due to cross-linking of FcεRI
What are the different phases of a type I hypersensitivity response? L28 S9
Immediate phase: -occurs within minutes -due to degranulation -vasodilation, congestion, and edema
Late phase: -occurs 2-24 hours later -due to leukocyte infiltration (eosinophils, neutrophils, t cells)
Summary of Type 1 Hypersensitivity:
- exposed to allergen
- antigen is then put on B cell and TH2 WILL recognize it and stimulate class switching
- production of IGE is made
- IGE will bind to FCER1 on mast cells
- repeat exposures will cause ag cross linking and activation of mast cells which release inflamatory mediators
Asthama
- caused by release of infammatory mediators from mast cells due to allergen
- will cause increase capillary permability and aspamodic contraction
- will decrease size of the bronchial lumen which will cause SOB
non immunologic stimuli such as ___ and ____ will also sitmulate airway inflamation and bronchospasms
cold, excersise
anaphylaxis (systemic reaction)
exposure to allergen –> mast cell relase of vasoactive substances of amines and cytokines from mast cells and basophils throughout the body resulting in contraction of smooth muslce of the vaslualtory and vasodilation of the capillary endothelim
- blood pressure drops causing vascular shock
- will make breathing difficult
allergen test
- test type 1 hypersentivities: either on arm or back
- make a grid and then inject it into the arm
- look for redness and swelling
What is allergen-SIT? L28 S13-14
Administration of allergen in increasing doses to cure allergies
Functions:
- induces T cell tolerance (Tregs)
- increase the treshold for mast and basophil actication by allergens
- decreased IgE-mediated histamine release
The generation of ITregs is key for this
What are the characteristics of type II hypersensitivity? L28 S16
- IgG/IgM interaction with cell/tissue SURFACE Ags
- those Igs activate complement and production of C3a and C5a anaphylatoxins resulting in leukocyte recruitment/ cause inflamation
- Opsonization of cell via IgG causing neutrophil and macrophage activation by FcR gamma or CR1 receptors
- also FC receptor dependent manner of (ab cellular cytotoxicity) will cause neutropils and macrophages to bind and release inflamatory mediators:
- ros and lysosomal enzymes released damage adjacent tisues and then cause inflamation
What are examples of type II hypersensitivity that don’t results in cell damage but instead have other physiological responses? L28 S18
Grave’s disease:
-binding of Ab to TSH receptor in thyroid, activating them -results in hyperthyroidism
Myasthenia gravis:
-binding of Ab to ACh receptor in neuromuscular synapses blocking stimulation
DIIHA
DRUG induced immune hemolytic anemia
- PCN: binds to erethrocyte and Ig bind to drug and causes hemolysis (pahgoyctosis or complement)
- QUINIDINE: autoantibodies form immune complexes with drug as the drug binds via c3b (hemolysis by complement)
METHYLODPA: pahgocytosis binds to rbc antigens
What are examples of type III hypersensitivity? L28 S25
- systemic lupus erythematosus (DNA)
- polyarteritis nodosa
- post-streptococcal glomerulonephritis
- serum sickness (systemic vasculitis)
- Arthus reaction (local vasculitis)